Liminal Biosciences (LMNL) Stock Highlights

8.5 | +0%

2023-10-26 16:28:09

Liminal Biosciences Inc is a clinical stage biopharmaceutical company focusedon developing distinctive novel small molecule therapeutics forinflammatory, fibrotic, and metabolic diseases using our drug discoveryplatform and a data driven approach. The company has activebusiness operations in Canada and the United Kingdom.

Statistics

Range Today

8.5 8.5

Volume Today 0

Range 1 Year

3.1 8.5

Volume 1 Year 11.79M

Range 3 Year

3.1 119.9

Volume 3 Year 38.38M

Range 10 Year

3.1 27739

Volume 10 Year 39.66M

Highlights

Market Capitalization 27.43M (micro)

Floating Shares 1.26M

Current Price 8.5

Price To Earnings -1.24

Price To Revenue 18.8

Price To Book 1.28

Earnings Per Share -6.77

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.83%

3 Months +34.49%

6 Months +121.35%

1 Year +73.47%

3 Years -92.31%

5 Years -99.78%

10 Years -99.92%

Benchmarks

Market Capitalization

316 / 368

Gross Profits

161 / 278

Total Revenue

257 / 300

Total Rank

330 / 368

Free Cashflow

133 / 352

Performance 5 years

367 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.